Holen Sie sich die Stockscreener-App
0.6221
0.00%
0.00
Handel nachbörslich:
.62
-0.00211
-0.34%
Schlusskurs vom Vortag:
$0.6221
Offen:
$0.661
24-Stunden-Volumen:
44,621
Relative Volume:
0.46
Marktkapitalisierung:
$1.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.00M
KGV:
-0.541
EPS:
-1.15
Netto-Cashflow:
$-3.85M
1W Leistung:
-15.93%
1M Leistung:
-61.60%
6M Leistung:
-83.76%
1J Leistung:
-91.89%
1-Tages-Spanne:
$0.5889
$0.72
1-Wochen-Bereich:
$0.5889
$0.72
52-Wochen-Spanne:
$0.5889
$14.28
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Firmenname
Protagenic Therapeutics Inc
Sektor
Branche
Telefon
(212) 994-8200
Adresse
149 FIFTH AVENUE, NEW YORK
Vergleichen Sie PTIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
0.6221 | 1.43M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Protagenic Therapeutics Inc Aktie (PTIX) Neueste Nachrichten
Is Protagenic Therapeutics Inc. Equity Warrant stock a contrarian buyQuarterly Growth Report & Breakout Confirmation Alerts - ulpravda.ru
Why Protagenic Therapeutics Inc. Equity Warrant stock is a must watch in 2025Market Movement Recap & Weekly Stock Breakout Alerts - ulpravda.ru
How Protagenic Therapeutics Inc. Equity Warrant stock performs in weak economyMarket Growth Review & Real-Time Buy Signal Notifications - ulpravda.ru
Trading Action: Is Protagenic Therapeutics Inc. Equity Warrant stock recession proof2025 Volatility Report & Low Risk Investment Opportunities - ulpravda.ru
Can Protagenic Therapeutics Inc. stock hit analyst price targetsGDP Growth & Long-Term Safe Investment Ideas - ulpravda.ru
Is Protagenic Therapeutics Inc. Equity Warrant stock affected by interest rate hikes2025 Short Interest & Weekly Breakout Watchlists - ulpravda.ru
Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong cash flowsJuly 2025 Price Swings & Long-Term Safe Return Strategies - ulpravda.ru
How Protagenic Therapeutics Inc. stock trades during market volatilityPortfolio Performance Summary & Weekly Breakout Watchlists - ulpravda.ru
Market Rankings: Is Protagenic Therapeutics Inc. Equity Warrant stock affected by interest rate hikesWeekly Risk Summary & Real-Time Stock Price Movement Reports - ulpravda.ru
Can Protagenic Therapeutics Inc. Equity Warrant stock continue upward trendJuly 2025 Decliners & AI Powered Buy/Sell Recommendations - ulpravda.ru
Protagenic Therapeutics, Inc.(NasdaqCM: PTIX) dropped from S&P TMI Index - MarketScreener
How Protagenic Therapeutics Inc. stock performs in high volatility markets2026 world cup usa national team group stage playmakers possession football winner prediction insights - ulpravda.ru
Protagenic Therapeutics to begin OTC trading after Nasdaq delisting - Investing.com
Protagenic Therapeutics Prepares for Nasdaq Delisting, OTC Trading - TipRanks
Protagenic Therapeutics to begin OTC trading after Nasdaq delisting By Investing.com - Investing.com India
Protagenic Therapeutics Received Notice of Delisting - TradingView — Track All Markets
Protagenic Therapeutics Inc. (PTIX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - Livingston Daily
Support Test: Is Protagenic Therapeutics Inc Equity Warrant stock affected by interest rate hikes2025 Trade Ideas & AI Driven Price Forecasts - moha.gov.vn
Protagenic Therapeutics receives Nasdaq non-compliance letter - MSN
EPS Watch: Is Protagenic Therapeutics Inc stock a buy on dips2025 Trade Ideas & Safe Capital Growth Plans - moha.gov.vn
ETF Watch: Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong fundamentalsQuarterly Portfolio Summary & Verified High Yield Trade Plans - moha.gov.vn
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive for income investorsQuarterly Growth Report & Expert Curated Trade Ideas - Улправда
Will Protagenic Therapeutics Inc. stock deliver shareholder valueJuly 2025 Breakouts & Verified Momentum Watchlists - Улправда
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - Newswire.com
Can Protagenic Therapeutics Inc. stock hit record highs againMarket Trend Summary & Capital Efficient Trade Techniques - Улправда
Published on: 2025-12-20 04:38:52 - Улправда
Why Protagenic Therapeutics Inc. stock remains undervalued2025 Volatility Report & Low Risk Profit Maximizing Plans - Улправда
Published on: 2025-12-19 23:10:33 - Улправда
Published on: 2025-12-19 21:59:06 - Улправда
Risk Hedge: Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong fundamentalsWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - Улправда
Will Protagenic Therapeutics Inc. stock reach all time highs in 2025Earnings Growth Summary & Risk Managed Trade Strategies - DonanımHaber
Will Protagenic Therapeutics Inc. stock split attract more investors2025 Investor Takeaways & Reliable Price Breakout Signals - DonanımHaber
Will Protagenic Therapeutics Inc. stock benefit from commodity pricesMarket Volume Summary & Technical Buy Zone Confirmation - Улправда
Can Protagenic Therapeutics Inc. stock maintain growth trajectoryMarket Activity Recap & Safe Entry Trade Signal Reports - Улправда
Resistance Check: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryJuly 2025 Pullbacks & Accurate Buy Signal Alerts - Улправда
Can Protagenic Therapeutics Inc. stock attract ESG capital inflowsWeekly Profit Summary & Stock Portfolio Risk Control - Улправда
Gap Down: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryQuarterly Trade Review & Growth-Oriented Investment Plans - Улправда
Published on: 2025-12-18 16:25:19 - Улправда
Protagenic Therapeutics Inc (PTIX) - MSN
What analysts say about Protagenic Therapeutics Inc stockValue Stock Picks & Rapid Capital Gain - earlytimes.in
Protagenic reports results from phase 1 multiple-dose study of PT00114 - MSN
Taking on analysts’ expectations and winning: Protagenic Therapeutics Inc (PTIX) - setenews.com
Protagenic Therapeutics (PTIX) Shares Phase 1 Study Results for PT00114 - GuruFocus
Protagenic reports positive safety results for stress disorder drug By Investing.com - Investing.com Canada
Protagenic reports positive safety results for stress disorder drug - Investing.com
Results from Phase 1 Multiple-Dose Study of PT00114 - ACCESS Newswire
Protagenic Therapeutics (NASDAQ: PTIX) reports positive Phase 1 multiple-dose safety data for PT00114 - Stock Titan
What Makes Kalyan Jewellers India Limited Stand Out Among CompetitorsSupport and Resistance Levels & Minimal Investment Portfolio - earlytimes.in
Will Protagenic Therapeutics Inc. (MBP0) stock profit from automation waveWeekly Trade Recap & Pattern Based Trade Signal System - Newser
Is Protagenic Therapeutics Inc. (MBP0) stock a buy before new product rollout2025 Support & Resistance & Daily Profit Focused Stock Screening - Newser
Finanzdaten der Protagenic Therapeutics Inc-Aktie (PTIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):